Profile
Hadean Ventures is a European venture capital firm focused on investments in the healthcare sector, with headquarters in Europe. The firm was founded to address complex, real-world challenges and unmet needs in life sciences. The core team includes Managing Partners Ingrid Teigland Akay and Walter Stockinger, alongside a complementary team of partners and investment associates. What sets Hadean Ventures apart is their commitment to science-driven innovation and impactful investing in the future of healthcare.
The firm invests in a range of healthcare sectors, which can include biotechnology, pharmaceuticals, and healthcare services, among others. They support businesses across various stages from early to later development stages. Hadean Ventures manages over EUR 230 million in assets, and they have a total of five funds. They position themselves as a partner of choice for innovation-driven ventures in Europe, but their specific check sizes and LPs are not detailed. Their investments also align with an impact focus as seen through their engagement with ESG principles.
The firm's portfolio includes companies across the healthcare spectrum, with more than 36 companies under management. However, specific notable companies within the portfolio are not listed. Their broader goal is to create significant value while contributing substantially to societal advancements through healthcare innovations.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.